Effects of Fatty Acid Amide Hydroxylase Inhibitor URB597 on the Catecholaminergic Activity of the Adrenal Medulla in Stressed Male and Female Rats.


Journal

Pharmacology
ISSN: 1423-0313
Titre abrégé: Pharmacology
Pays: Switzerland
ID NLM: 0152016

Informations de publication

Date de publication:
2022
Historique:
received: 19 05 2021
accepted: 26 08 2021
pubmed: 19 11 2021
medline: 1 2 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

The present study examined the effects of fatty acid amide hydrolase inhibitor URB597 on the level of plasma catecholamine and their content, synthesis, and degradation in the adrenal medulla of male and female rats subjected to chronic unpredictable stress (CUS). Male and female Wistar rats were exposed to the 6 weeks of CUS and treated intraperitoneally with either 0.3 mg/kg/day of URB597 or vehicle in the last 2 weeks of stress protocol. Catecholamines' plasma levels and catecholamines' levels in adrenal medulla were examined using Elabscience ELISA kits. Western blot analysis was used to detect the protein in the medulla. The results of our experiment showed that adrenal weights and catecholamine of unstressed control were higher in females and that CUS induced further enlargement of adrenal glands and catecholamine content and its synthesis compared to male rats. CUS caused an increase of plasma norepinephrine and depletion of norepinephrine content as well as unchanged synthesis and degradation of catecholamine in the adrenal medulla of male rats. URB597 reduced enlarged adrenals and catecholamine content and its synthesis in stressed female rats. URB597 reduces increased plasma norepinephrine and restores its content in the adrenal medulla, unchanging the expression of enzyme synthesis, while reduced protein levels of monoamine oxidase A in male rats are exposed to CUS. Our results support the role of endocannabinoids as an antistress mechanism that inhibits elevated adrenomedullary activation and promotes its recovery to baseline in both male and female stressed rats.

Identifiants

pubmed: 34794150
pii: 000519332
doi: 10.1159/000519332
doi:

Substances chimiques

Benzamides 0
Carbamates 0
Catecholamines 0
Endocannabinoids 0
cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester 0
Monoamine Oxidase EC 1.4.3.4
Catechol O-Methyltransferase EC 2.1.1.6
Comt protein, rat EC 2.1.1.6
Amidohydrolases EC 3.5.-
fatty-acid amide hydrolase EC 3.5.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-89

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Harisa Ferizovic (H)

Department of Molecular Biology and Endocrinology, Institute of Nuclear Sciences "Vinca", National Institute of thе Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Natasa Spasojevic (N)

Department of Molecular Biology and Endocrinology, Institute of Nuclear Sciences "Vinca", National Institute of thе Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Milica Jankovic (M)

Department of Molecular Biology and Endocrinology, Institute of Nuclear Sciences "Vinca", National Institute of thе Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Bojana Stefanovic (B)

Department of Molecular Biology and Endocrinology, Institute of Nuclear Sciences "Vinca", National Institute of thе Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Sladjana Dronjak (S)

Department of Molecular Biology and Endocrinology, Institute of Nuclear Sciences "Vinca", National Institute of thе Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH